Superoxide Dismutase and Oxidative Stress in Amyotrophic Lateral Sclerosis by Franco, María Clara et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 5
Superoxide Dismutase and Oxidative Stress in
Amyotrophic Lateral Sclerosis
María Clara Franco, Cassandra N. Dennys,
Fabian H. Rossi and Alvaro G. Estévez
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/56488
1. Introduction
Oxidative stress is defined as the imbalance between reactive species such as free radicals and
oxidants and the antioxidant defenses. Free radicals are molecules with one or more unpaired
electrons, while oxidants are molecules with a high potential for taking electrons from other
molecules. The more recognized reactive species are the reactive oxygen species (ROS), which
include oxygen and its reduction products superoxide, hydrogen peroxide and hydroxyl
radical, and the reactive nitrogen species (RNS) such as the free radical nitric oxide and its by-
products, including the powerful oxidant peroxynitrite and the sub-product of peroxynitrite
decomposition nitrogen dioxide.
As part of the antioxidant defense system, superoxide dismutase 1 (SOD1) is an abundant and
highly conserved cytosolic enzyme responsible for the disproportionation of superoxide to
molecular oxygen and hydrogen peroxide (McCord and Fridovich, 1969). SOD1 is a relatively
small protein of 153 amino acids that works as a tight homodimer and requires a high stability
for fast catalysis (Perry et al., 2010; Trumbull and Beckman, 2009). The stability is conferred by
the quaternary structure of the protein, an eight-strand beta-barrel, as well as the binding of
Cu and Zn, two metal ions with catalytic roles positioned in the active site channel (Perry et
al., 2010; Trumbull and Beckman, 2009). The disproportionation of superoxide is a two-step
oxidation-reduction reaction that involves the cycling of the copper atom in SOD1 from Cu2+
to Cu+ and back to Cu+2.
The zinc does not participate in this reaction but is essential for the structure of the active site.
In addition, the formation of an intrasubunit disulfide bridge stabilizes the enzyme and plays
an important role in preventing aggregation of metal-deficient SOD (Getzoff et al., 1989).
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Mutations in the gene codifying for SOD1 were linked to familial ALS almost 20 years ago.
Currently, over 130 point mutations on more than 70 sites on SOD1 have been described, most
of these being missense single residue mutations located in critical positions that affect the
stability and folding of the enzyme (Beckman et al., 2001; Perry et al., 2010; Roberts et al.,
2007). The goal of this chapter is to review recent advances in our understanding of the role of
oxidative stress on the gain of a toxic function associated with mutations in the gene of the
copper/zinc superoxide dismutase.
2. Zn-deficient SOD1
The first proposed mechanisms linking mutations of SOD1 with ALS were based on the loss
of dismutase activity (Beckman et al., 1993; Deng et al., 1993a). However, the SOD1 mutants
G37R and G93A remain fully active and were linked to familial ALS (Borchelt et al., 1994; Yim
et al., 1996). In addition, the mouse knockout for SOD1 developed normally and did not show
signs of motor neuron deficit, although the motor neurons were more susceptible to cell death
upon axonal injury (Reaume et al., 1996). This evidence indicated that a gain-of-function rather
than the loss of function was responsible for motor neuron degeneration in ALS, and that the
gain-of-function could be related to the redox properties of SOD1.
The discovery that mutations on the gene for an antioxidant enzyme such as SOD1 were
associated with a population of familial ALS patients led to speculate on the role of oxidative
stress in the pathogenesis of ALS (Beckman et al., 1993; Deng et al., 1993b; Rosen et al., 1993).
From this original discovery to the present the interest on oxidative stress in ALS has been a
rollercoaster. Several different groups described the presence of a variety of markers for
oxidative stress in human samples and animal models of ALS, including elevated protein
carbonyl and nitrotyrosine levels as well as lipid and DNA oxidation. Oxidation of proteins,
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lipids, and DNA was also found in transgenic mice and cell culture models (Barber and Shaw,
2010). On the other hand, other groups failed to find markers of oxidative damage in animal
models of ALS, casting doubt on the relevance of oxidative stress in the pathogenesis of the
disease (Barber and Shaw, 2010). Currently, a role for oxidative stress in ALS is generally
accepted but whether oxidative stress is responsible for the mutant SOD1 gain-of-function is
still controversial.
2.1. Mutant SOD1 aggregation and Zn-deficiency
Mutant SOD1s have a tendency to aggregate when expressed in bacterial systems and
transfected cells, and the presence of mutant and wild type SOD1-containing aggregates has
been described in animal models of ALS (Bruijn and Cleveland, 1996; Watanabe et al., 2001).
The formation of aggregates clogging the proteasome and containing other relevant proteins
along with mutant SOD1 is one of the possible explanations for SOD1 toxic gain-of-function.
However, in mice expressing the SOD1A4V mutant, the most common mutation linked to
familial ALS in humans, the mutant is expressed at high levels and forms protein aggregates
but does not cause disease (Gurney et al., 1994). Alternatively, other groups proposed a
hypothesis in which the formation of aggregates is a protective mechanism rather than cause
of toxicity. In vitro experiments showed that both wild type SOD1 and SOD1 with mutation of
the cysteine residues involved in protein aggregation were able to stabilize the mutant SOD1
enzymes, increasing their toxicity (Clement et al., 2003; Fukada et al., 2001; Sahawneh et al.,
2010; Witan et al., 2009). Additionally, it was recently described that overexpression of the
deubiquitinating enzyme ataxin-3 stimulates the formation of SOD1-containing aggresomes
by trimming K63-linked polyubiquitin chains. The knockdown of ataxin-3 decreases the
formation of aggresomes and increases cell death induced by mutant SOD1 (Wang et al.,
2012). These results suggest a toxic gain-of-function for the stabilized and soluble mutant
SOD1, rather than toxicity due to aggregation. Indeed, by removing the toxic soluble mutant
SOD1, the formation of aggregates has been proposed to be a protective mechanism (Trumbull
and Beckman, 2009). Further support is provided by recent studies of crossbreeding showing
an acceleration of the disease in mutant SOD1 transgenic mice overexpressing wild type SOD1,
which was linked to the formation of disulfide bridges in the enzyme by oxidation of cysteine
residues, increasing the formation of aggregates (Deng et al., 2006; Furukawa et al., 2006; Wang
et al., 2009). Other investigations reproduced the acceleration of the disease in animals
expressing both wild type and mutant SOD1 but failed to find a correlation between expression
of wild type SOD1 and protein aggregation (Prudencio et al., 2009).
The link between the gain-of-function and the redox activity of soluble mutant SOD1 as a
source of oxidative stress is based on the presence of the copper atom in the active site of the
enzyme as well as the loss of zinc. The requirement for copper was challenged by genetic
experiments in which the chaperone that delivers the copper metal to SOD1 was deleted. The
ablation of the chaperone in the G93A, G85R, or G73R-SOD1 mutant mice decreased the
activity of the enzyme but had no effect on the progression of the disease (Subramaniam et al.,
2002), although it may be possible for SOD1 to acquire copper from an alternative source
(Beckman et al., 2002). The transgenic expression of a SOD1 with mutations that eliminate the
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copper-binding site still produced disease (Prudencio et al., 2012; Wang et al., 2003). In contrast,
another study showed that the mutant enzymes A4V, G85R, and G93A had a higher affinity
for copper than the wild type protein, and that this aberrant copper binding was mediated by
cysteine 111 (Watanabe et al., 2007), implying that the enzyme binds copper in an alternate site
(Figure 1A).
Some SOD1 mutants bind copper and zinc and are fully active (Borchelt et al., 1994; Marklund
et al., 1997) but many mutations affect the binding of zinc while copper remains tightly bound,
thus favoring the formation of Zn-deficient SOD. In the SOD1G93A mouse model of ALS, the
dietary depletion of zinc accelerates the progression of the disease while moderate supplement
of zinc provides protection (Ermilova et al., 2005). Indeed, a peak corresponding to one-metal
SOD1 was detected in vivo in spinal cords from the SOD1G93A rat model using the recently
developed methodology of electrospray mass spectrometry. The one-metal peak was 2-fold
larger in the disease-affected ventral spinal cord compare to that of the dorsal spinal cord
(Rhoads et al., 2011), suggesting that Zn-deficient SOD1 may be present in vivo in the affected
tissue.
ALS-linked mutant SOD1s have 5-50 fold less affinity for zinc than the wild type protein (Crow
et al., 1997a; Lyons et al., 1996). The loss of zinc disorganizes the structure of the active site
leaving the copper metal more expose and accessible to substrates other than superoxide,
decreasing the normal activity of the enzyme. When replete with zinc, SOD1 mutants can
generally fulfill the antioxidant activity of wild type SOD (Crow et al., 1997a). Early studies
showed that mutant SOD1 has an aberrant chemistry and is reduced abnormally fast which
allows the reaction with oxidants such as hydrogen peroxide and peroxynitrite (Crow et al.,
1997a; Crow et al., 1997b; Lyons et al., 1996; Wiedau-Pazos et al., 1996), thus turning the
antioxidant enzyme into a catalyst for oxidation. The conversion of SOD1 from antioxidant to
pro-oxidant due to the loss of zinc is a simple explanation for the gain-of-function attributed
to the ALS-linked SOD mutants, but is still highly controversial.
2.2. Formation of hydroxyl radical from hydrogen peroxide
In normal conditions SOD1 catalyzes the disproportionation of superoxide to hydrogen
peroxide, but due to changes in mutant SOD1 conformation, the mutant enzyme can catalyze
the production of hydroxyl radical from hydrogen peroxide in vitro (Yim et al., 1990) (Figure
1B). The G93A-SOD1 mutant has enhanced free-radical production compare to the wild type
enzyme due to a more open active site, decreasing the Km for hydrogen peroxide (Yim et al.,
1996). Accordingly, an increase in the levels of hydrogen peroxide and hydroxyl radical was
reported in vivo in the spinal cord from mice expressing the G93A mutant (Liu et al., 1999).
The aberrant chemistry of mutant SOD1 was shown to inactivate the glutamate transporter
EAAT2 by oxidative reactions catalyzed by the A4V and I113T-SOD1 mutants and triggered
by hydrogen peroxide (Trotti et al., 1999; Trotti et al., 1996). The function of this transporter is
down regulated in human patients and animal models of ALS and its inactivation results in
neuronal degeneration (Rothstein et al., 2005; Tanaka et al., 1997). Moreover, the aberrant SOD1
chemistry increases the vulnerability of a variety of cells in culture to hydrogen peroxide, with
an increased susceptibility to inhibition by copper chelators. The G37R, G41D, and G85R-SOD1
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mutants induce activation of caspase 1 and promoted apoptosis in N2a cells and tissue
expressing mutant SOD1 when exposed to hydrogen peroxide. In NSC34 cells, a motor neuron
model, mutant SOD1 induces cell death upon exposure of the cells to hydrogen peroxide
(Pasinelli et al., 1998; Wiedau-Pazos et al., 1996). These findings suggest that the ALS pheno‐
type may require both, the genetic background and an additional oxidative challenge.
2.3. Production of peroxynitrite
Nitric oxide alone is not toxic to normal motor neurons (Estévez et al., 1999), but when
superoxide is also produced it can react with nitric oxide to form the powerful oxidant
peroxynitrite, responsible for the induction of cell death. Overexpression of mutant SOD1
makes motor neurons vulnerable to exogenous and endogenous production of nitric oxide.
The increased vulnerability is linked to the activation of the Fas death pathways (Raoul et al.,
2002). More recently it was shown that motor neurons from mutant SOD1 transgenic animals
have lower levels of a calcium-binding ER chaperone calreticulin. A decrease in the expression
of this protein is necessary and sufficient to activate the Fas/NO pathways in motor neurons.
Further evidence in vivo shows that this protein is decreased in the spinal motor neurons of
SOD1G93A transgenic animals prior to muscle denervation (Bernard-Marissal et al., 2012).
Therefore, motor neurons expressing mutant SOD1 may produce superoxide making them
susceptible to the formation of peroxynitrite in the presence of nitric oxide. In the presence of
reductants, Zn-deficient SOD1 is able to produce superoxide. For instance, ascorbate reduces
the copper on Zn-deficient SOD1 from Cu2+ to Cu+. In turn, Zn-deficient SOD1 can transfer
the electrons from ascorbate to oxygen to produce superoxide slowly but significantly over a
period of minutes. Indeed, Zn-deficient SOD1 is able to oxidize ascorbate 3000-fold faster than
mutant or wild type Cu,Zn-SOD1 in vitro (Estévez et al., 1999). In the cells, ascorbate and other
cellular antioxidants such as glutathione, urate, and cysteine could have a similar effect.
Normally, superoxide would be removed by the dismutase activity of the remaining and fully
active Cu,Zn-SOD1. However, if nitric oxide is also produced it can effectively compete with
Cu,Zn-SOD1 for superoxide to produce peroxynitrite. Because nitric oxide is a small molecule
able to diffuse 10-fold faster than a small size protein, the reaction of nitric oxide with super‐
oxide occurs 10 times faster than that with SOD1 (Beckman et al., 2001; Estévez et al., 1999;
Franco and Estévez, 2011; Nauser and Koppenol, 2002) (Figure 1B). Wild type Cu,Zn-SOD1
can also produce peroxynitrite by a similar mechanism but requires superoxide in the initial
step to be efficiently reduced (Beckman et al., 2001).
2.4. Catalysis of tyrosine nitration
Cu,Zn-SOD1 is not only responsible for the production of peroxynitrite but it can also catalyze
tyrosine nitration in vitro (Beckman et al., 1993; Crow et al., 1997b; Ischiropoulos et al., 1992).
The mechanism for tyrosine nitration depends on the copper atom in SOD1 that reacts with
peroxynitrite. The loss of zinc from Cu,Zn-SOD1 increases by 2-fold the efficiency of the
enzyme to catalyze tyrosine nitration (Crow et al., 1997a) (Figure 1B). Moreover, SOD1 is not
inactivated by peroxynitrite and can catalyze tyrosine nitration indefinitely. Indeed, reactivity
for nitrotyrosine was found in vivo in the SOD1G93A mouse model and in patients with ALS
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(Beal et al., 1997; Ferrante et al., 1997). In spite of the indirect evidence of mass spectrometry
showing a peak corresponding to a one-metal SOD1 in a rat model of ALS (Rhoads et al.,
2011), whether Zn-deficient SOD1 is present in vivo and catalyzes tyrosine nitration is still
source of debate and remains to be determined.
3. Regulation of NADPH oxidase activity by mutant SOD1
Several lines of evidence support the role of oxidative stress in mutant SOD1 toxicity, but some
evidence suggest that interactions other than the redox properties of the enzyme stimulate
oxidative stress by different mechanisms. Mutant SOD1 can induce oxidative stress by
disruption of the redox-sensitive regulation of NADPH oxidase (Nox) in microglial cells. Noxs
are transmembrane proteins that catalyze the reduction of oxygen to superoxide using
NADPH as an electron donor (Brown and Griendling, 2009). Superoxide is then converted to
hydrogen peroxide by SOD1. Under reducing conditions, SOD1 regulates Nox2 activation by
binding and stabilizing Rac1. The oxidation of Rac1 by hydrogen peroxide disrupts the
complex with SOD1 and inactivates Nox2. Upon expression of certain ALS SOD1 mutants, the
dissociation of Rac1 from SOD1 is impaired and Nox2 remains active (Figure 1C). In addition,
the expression of Nox2 is upregulated in the SOD1G93A mouse model and in ALS patients. In
fact, gene deletion of Nox1 or Nox2 provides the larger protection to date in animal models of
ALS (Harraz et al., 2008; Marden et al., 2007).
4. Mutant SOD1 translocation to mitochondria
Mitochondria are one of the major sources of cellular ROS formed as by-products of oxidative
phosphorylation. Abnormalities in the mitochondrial structure, localization and number as
well as altered activity of the electron transport chain have been described in both, sporadic
and familial ALS (Manfredi and Xu, 2005). The mitochondrial electron transport chain and
ATP synthesis are severely impaired at disease onset in spinal cord and brain of SOD1G93A
transgenic mice (Lin and Beal, 2006). Both, wild type and mutant SOD localize in mitochondria
in the central nervous system (Higgins et al., 2002). Mutant human SOD1 was found in the
mitochondrial outer membrane, intermembrane space and matrix in transgenic mice, while
inactive mutant SOD1 accumulates and forms aggregates in the mitochondrial matrix in the
brain (Vijayvergiya et al., 2005). Aggregates of the mutant enzyme are also selectively found
in the mitochondrial outer membrane in spinal cord from mouse models of ALS (Liu et al.,
2004). Interestingly, the anti-apoptotic protein Bcl-2 binds to mutant SOD1 and aggregates in
spinal cord mitochondria from patients and a mouse model of ALS, suggesting that mutant
SOD1 may be toxic by depleting motor neurons of this anti-apoptotic protein (Pasinelli et al.,
2004). Mutant SOD1 targeted to the mitochondrial intermembrane space in NSC34 cells
induces cell death upon exposure of the cells to hydrogen peroxide (Magrane et al., 2009). In
addition, the increase in carbonylated proteins and lipid hydroperoxides in mitochondria, as
well as the abnormally high rates of production of hydrogen peroxide in SOD1G93A transgenic
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mice (Mattiazzi et al., 2002; Panov et al., 2011) support the mutant SOD1 aberrant catalytic
gain-of-function. Indeed, it was shown that metal-deficient SOD1s are prone to mitochondrial
translocation and are found in the mitochondrial intermembrane space (Okado-Matsumoto
and Fridovich, 2002). The mitochondria contain the majority of the cellular copper because is
required by the oxygen-consuming proteins. The insertion of copper into the translocated
metal-deficient SOD would result in the formation of Zn-deficient SOD inside the mitochon‐
dria (Figure 1A). This could explain why the mitochondria are affected early in the onset of
the disease (Beckman et al., 2002). The ROS-linked toxic gain-of-function of mutant SOD1
would produce hydroxyl radical from H2O2 as well as peroxynitrite in the mitochondria. The
mutant enzyme could then catalyze the nitration of mitochondrial proteins such as cyclophilin
D and the adenine nucleotide translocator (Martin, 2010). Due to these toxic effects of mutant
SOD1 on mitochondria, it has been proposed that the abnormal activity of the mitochondria
in ALS may account for the initiation and progression of the disease. However, whether the
mitochondrial localization of mutant SOD1 is cause or a consequence of pathology needs to
be established.
5. Expression of mutant SOD1 in motor neurons and neighboring cells
A new mechanism integrating the autonomous and non-autonomous induction of motor
neuron death in ALS is emerging. In this scenario, the role of motor neurons and surrounding
cells in the onset and progression of ALS is temporally determined. Several studies were
conducted where mutant SOD1 was selectively expressed in vivo either in motor neurons or
microglia of chimeric mice, or in culture in embryonic primary or stem cell-based models,
allowing the study of the role of individual population of cells in the onset and progression of
ALS. The cell-autonomous degeneration of motor neurons expressing mutant SOD1 seems to
be more relevant for the onset and early progression of the disease, while microglia, peripheral
macrophages, and astrocytes would play a role in the late disease progression.
5.1. Expression of mutant SOD1 in motor neurons
ALS is a motor neuron disease characterized by the gradual and selective loss of both, upper
and lower motor neurons. Expression of mutant SOD1 in spinal motor neurons and inter‐
neurons of chimeric mice is enough to induce neuronal degeneration (Boillee et al., 2006; Wang
et al., 2008). The mice do not develop clinical ALS but the motor neurons expressing mutant
SOD1 exhibit pathological and immunohistochemical abnormalities, while motor neurons
negative for mutant SOD1 expression do not. These observations indicate that in the chimeric
mice the degeneration of motor neurons can be cell-autonomous. The fact that only some of
the motor neurons express mutant SOD1 in this model may explain why the animals do not
develop the disease (Wang et al., 2008). Indeed, normal motor neurons can prevent or delay
the degeneration of mutant SOD1-expressing motor neurons (Clement et al., 2003). In addition,
decreased expression of mutant SOD1 in motor neurons has a modest effect on the duration
of the disease but significantly delay the onset and early phase of the disease progression
(Wang et al., 2008). Similar results were observed in culture, where primary spinal motor
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neurons as well as embryonic stem cell-derived motor neurons expressing mutant SOD1
showed changes characteristic of neurodegeneration (Di Giorgio et al., 2007; Raoul et al.,
2002). Primary embryonic motor neurons from SOD1G93A and SOD1G85R transgenic animals
exposed to endogenously produced or exogenously added nitric oxide show an increased
susceptibility to cell death in culture (Raoul et al., 2002). Thus, motor neurons expressing
mutant SOD1 are susceptible to cell death stimulated by oxidative stress.
5.2. Expression of mutant SOD1 in glial cells
Neighboring cells also seem to play a role in mutant SOD1 toxicity. Normal motor neurons in
the context of a mutant SOD1-expressing chimera show signs of neurodegeneration, while
non-neuronal cells negative for mutant SOD1 expression delay neuronal degeneration and
significantly extend survival of mutant-expressing motor neurons (Clement et al., 2003). In the
Figure 1. Role of oxidative stress in mutant SOD1 toxic gain-of-function. A. The toxic gain-of-function depends on
the redox properties of the enzyme and relies on the copper atom. The mutant SOD1 translocates to mitochondria,
while the metal-deficient enzyme may translocate and bind copper in the organelle. B. Zn-deficient SOD1 as catalyst
of ROS production and tyrosine nitration. C. Mutant SOD1 regulation of ROS production by Noxs. NO2-Tyr: nitrotyro‐
sine, HO.: hydroxyl radical, O2: molecular oxygen, ONOO-: peroxynitrite, NO.: nitric oxide, O2.-: superoxide.
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last few years, a role for microglia and astrocytes in the induction of motor neuron death has
become evident.
5.2.1. Role of microglia in the induction of motor neuron death
Activated microglia is found in the spinal cord of SOD1G93A transgenic mice, suggesting that
it may play a role in the neurodegeneration of neighboring motor neurons (Beers et al., 2006).
Reducing the expression of mutant SOD1 in microglia and peripheral macrophages in chimeric
mice leads to a delay in the late progression of ALS but has little effect on the onset and early
disease progression (Boillee et al., 2006). Likewise, in the PU.1(-/-)/SOD1G93A mice unable to
synthesize myeloid cells, the replacement of microglia, monocyte, and macrophage lineages
with genotypically identical wild type cells slows disease progression and extends overall
survival (Beers et al., 2006), suggesting that non cell-autonomous effects contribute to ALS
progression independently of disease onset. Comparable findings were observed in co-culture
studies where glial cells expressing mutant-SOD1 had a direct adverse effect on motor neuron
survival (Di Giorgio et al., 2007). Microglia expressing G93A-SOD1 is toxic to primary motor
neurons in vitro. In addition, SODG93A microglia show an increase in superoxide and nitric oxide
production and release respect to wild type microglia. Treatment with lipopolysaccharide
further increases SODG93A microglia activation and induction of motor neuron death (Beers et
al., 2006). Hence, mutant SOD1-expressing microglia is activated, is more susceptible to
activation, and it is capable of inducing motor neuron death in vitro (Beers et al., 2006).
Interestingly, PU.1(-/-) mice transplanted with bone marrow from a SOD1G93A donor do not
develop clinical or pathological evidence of ALS, suggesting that expression of mutant SOD1
in microglia is not enough to induce motor neuron disease in vivo (Beers et al., 2006). The fact
that expression of mutant SOD1 in microglia alone does not induce motor neuron degeneration
suggests that motor neurons and other glial cells play a role in the pathological process. Indeed,
motor neurons expressing mutant SOD1 are more susceptible to cell death induced by
exposure to nitric oxide or Fas activation (Raoul et al., 2002).
5.2.2. Role of astrocytes in the induction of motor neuron death
Astrocytes are the most abundant non-neuronal cells in the nervous system. The co-culture of
normal primary embryonic or stem cell-derived motor neurons with astrocytes expressing
mutant SOD1 result in motor neuron death. The death pathway is triggered by a toxic factor
released by the astrocytes (Aebischer et al., 2011; Nagai et al., 2007). A population of pheno‐
typically aberrant astrocytes was recently described in the SOD1G93A mouse model of ALS
(Diaz-Amarilla et al., 2011). These astrocytes, referred to as “AbA cells”, have an increased
proliferative capacity and secrete soluble factors that are 10 times more potent than neonatal
SOD1G93A astrocytes for the induction of motor neuron death. AbA cells are present in
degenerating spinal cord of SODG93A rats surrounding affected motor neurons, and their
number increases dramatically after disease onset, highlighting the importance of this finding.
Interestingly, the levels of interferon-γ (IFNγ) are significantly increased in mutant SOD1-
expressing astrocytes, and IFNγ induces motor neuron death (Aebischer et al., 2011), suggest‐
ing that this cytokine may be one of the toxic factors mediating induction of cell death (Figure
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2). The role of astrocytes in the induction of motor neuron death was recently confirmed in
astrocytes generated from post-mortem tissue of familial and sporadic ALS patients, addi‐
tionally providing an in vitro model system for the study of these mechanisms (Haidet-Phillips
et al., 2011).
Figure 2. Model for the role of motor neurons and glia in the ROS-mediated ALS progression. Different cell types
are affected and play a role at different stages of the disease. During the onset and early disease progression, motor
neurons undergo degeneration and cell death by cell-autonomous mechanisms. Later in the disease progression, acti‐
vated microglia and astrocytes release ROS, RNS, and toxic factors that magnify the injury (cell death amplification
mechanisms).
6. Conclusion
In summary, the mechanism of mutant SOD1 toxicity is unknown and highly controversial
but there is strong evidence suggesting that the mutant SOD1 toxic gain-of-function is related
to an alteration of its redox properties and the induction of oxidative stress. In this scenario,
the aberrant chemistry of mutant SOD1 turns the enzyme from antioxidant to pro-oxidant. Zn-
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deficient SOD1 reacts with hydrogen peroxide, produces superoxide and peroxynitrite, and
is able to catalyze tyrosine nitration, altering the cellular redox balance. In addition, although
not related to the redox properties of the enzyme, the interaction of mutant SOD1 with
mitochondria and Nox, the two major sources of cellular ROS, further support the involvement
of oxidative stress in the toxic gain-of-function. The cell type affected by mutant SOD1 is also
controversial. A picture in which several cell types are affected and play a role at different
stages of the disease seems to be emerging. In this context, during onset and early stages of
the disease SOD1-expressing motor neurons undergo neurodegeneration and cell death by
cell-autonomous processes. The activation of microglia and astrocytes may work as an
amplification mechanism in the induction of motor neuron death in the late progression of the
disease (Figure 2).
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